Survival and associated comorbidities in inclusion body myositis.

ABSTRACT:

Objective

To evaluate survival and associated comorbidities in inclusion body myositis (IBM) in a population-based, case-control study.

Methods

We utilized the expanded Rochester Epidemiology Project medical records-linkage system, including 27 counties in Minnesota and Wisconsin, to identify patients with IBM, other inflammatory myopathies (IIM), and age/sex-matched population-controls. We compared the frequency of various comorbidities and survival among groups.

Results

We identified 50 IBM patients, 65 IIM controls and 294 population controls. Dysphagia was most common in IBM (64%) patients. The frequency of neurodegenerative disorders (dementia/parkinsonism) and solid cancers was not different between groups. Rheumatoid arthritis was the most common rheumatic dise

SUBMITTER: Naddaf E 

PROVIDER: S-EPMC9071572 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature